75 related articles for article (PubMed ID: 37424803)
1. Super enhancer inhibitors suppress MYC driven transcriptional amplification and tumor progression in osteosarcoma.
Chen D; Zhao Z; Huang Z; Chen DC; Zhu XX; Wang YZ; Yan YW; Tang S; Madhavan S; Ni W; Huang ZP; Li W; Ji W; Shen H; Lin S; Jiang YZ
Bone Res; 2018; 6():11. PubMed ID: 29644114
[TBL] [Abstract][Full Text] [Related]
2. Non-nuclear Pool of Splicing Factor SFPQ Regulates Axonal Transcripts Required for Normal Motor Development.
Thomas-Jinu S; Gordon PM; Fielding T; Taylor R; Smith BN; Snowden V; Blanc E; Vance C; Topp S; Wong CH; Bielen H; Williams KL; McCann EP; Nicholson GA; Pan-Vazquez A; Fox AH; Bond CS; Talbot WS; Blair IP; Shaw CE; Houart C
Neuron; 2017 May; 94(4):931. PubMed ID: 28521142
[No Abstract] [Full Text] [Related]
3. Correction: WWOX promotes osteosarcoma development via upregulation of Myc.
Akkawi R; Hidmi O; Haj-Yahia A; Monin J; Diment J; Drier Y; Stein GS; Aqeilan RI
Cell Death Dis; 2024 Feb; 15(2):141. PubMed ID: 38355659
[No Abstract] [Full Text] [Related]
4. Established and Evolving Roles of the Multifunctional Non-POU Domain-Containing Octamer-Binding Protein (NonO) and Splicing Factor Proline- and Glutamine-Rich (SFPQ).
Yu D; Huang CJ; Tucker HO
J Dev Biol; 2024 Jan; 12(1):. PubMed ID: 38248868
[TBL] [Abstract][Full Text] [Related]
5. The splicing factor proline and glutamine rich promotes the growth of osteosarcoma via the c-Myc signaling pathway.
Mao L; Jiang P; Lei X; Zhang B; Zhong X; Yin Z; Wang Y; Li D; Zhang Y; Zheng Q
Am J Cancer Res; 2023; 13(6):2488-2503. PubMed ID: 37424803
[TBL] [Abstract][Full Text] [Related]
6. Splicing factor proline and glutamine rich intron retention, reduced expression and aggregate formation are pathological features of amyotrophic lateral sclerosis.
Hogan AL; Grima N; Fifita JA; McCann EP; Heng B; Fat SCM; Wu S; Maharjan R; Cain AK; Henden L; Rayner S; Tarr I; Zhang KY; Zhao Q; Zhang ZH; Wright A; Lee A; Morsch M; Yang S; Williams KL; Blair IP
Neuropathol Appl Neurobiol; 2021 Dec; 47(7):990-1003. PubMed ID: 34288034
[TBL] [Abstract][Full Text] [Related]
7. DLX5 promotes osteosarcoma progression via activation of the NOTCH signaling pathway.
Zhang X; Bian H; Wei W; Wang Q; Chen J; Hei R; Chen C; Wu X; Yuan H; Gu J; Lu Y; Cai C; Zheng Q
Am J Cancer Res; 2021; 11(6):3354-3374. PubMed ID: 34249467
[TBL] [Abstract][Full Text] [Related]
8. Study of Splicing Factor, Proline- and Glutamine-rich by Proteomic Techniques in Human Malignant and Nonmalignant Cell Lines.
Pashintseva NV; Shishkin SS; Lisitskaya KV; Kovalev LI; Kovaleva MA; Eryomina LS; Kamenikhina IA; Novikova LA; Sadykhov EG
Protein Pept Lett; 2016; 23(11):958-966. PubMed ID: 27633854
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-1296 Facilitates Proliferation, Migration And Invasion Of Colorectal Cancer Cells By Targeting SFPQ.
Tao Y; Ma C; Fan Q; Wang Y; Han T; Sun C
J Cancer; 2018; 9(13):2317-2326. PubMed ID: 30026827
[TBL] [Abstract][Full Text] [Related]
10. CircECE1 activates energy metabolism in osteosarcoma by stabilizing c-Myc.
Shen S; Yao T; Xu Y; Zhang D; Fan S; Ma J
Mol Cancer; 2020 Oct; 19(1):151. PubMed ID: 33106166
[TBL] [Abstract][Full Text] [Related]
11. Multi-omics analysis identifies osteosarcoma subtypes with distinct prognosis indicating stratified treatment.
Jiang Y; Wang J; Sun M; Zuo D; Wang H; Shen J; Jiang W; Mu H; Ma X; Yin F; Lin J; Wang C; Yu S; Jiang L; Lv G; Liu F; Xue L; Tian K; Wang G; Zhou Z; Lv Y; Wang Z; Zhang T; Xu J; Yang L; Zhao K; Sun W; Tang Y; Cai Z; Wang S; Hua Y
Nat Commun; 2022 Nov; 13(1):7207. PubMed ID: 36418292
[TBL] [Abstract][Full Text] [Related]
12. Dissecting the Role of Circular RNAs in Sarcomas with Emphasis on Osteosarcomas.
Lakiotaki E; Kanakoglou DS; Pampalou A; Karatrasoglou EA; Piperi C; Korkolopoulou P
Biomedicines; 2021 Nov; 9(11):. PubMed ID: 34829872
[TBL] [Abstract][Full Text] [Related]
13. LncRNA KASRT Serves as a Potential Treatment Target by Regulating SRSF1-Related KLF6 Alternative Splicing and the P21/CCND1 Pathway in Osteosarcoma: An
Chen K; Li C; Huang S; Chen Y; Zhu X
Front Oncol; 2021; 11():700963. PubMed ID: 34568030
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
